Cover Image

Fe de errores de "Evaluación económica de rituximab en combinación con fludarabina y ciclofosfamida en comparación con fludarabina y ciclofosfamida en el tratamiento de la leucemia linfática crónica" Erratum to "Economic evaluation of rituximab added to fludarabine plus cyclophosphamide versus fludarabine plus cyclophosphamide for the treatment of chronic lymphocytic leukemia"

Saved in:

Bibliographic Details
Main Authors:	Luis Felipe Casado (Author), José Antonio García Marco (Author), Florinda Gilsanz (Author), Marcos González (Author), Eduardo Ríos (Author), Javier de la Serna (Author), Álvaro Urbano (Author), Vicente Vicente (Author), Carlos Rubio-Terrés (Author), Antonio J. Castro (Author)
Format:	Book
Published:	Elsevier, 2011-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluación económica de rituximab en combinación con fludarabina y ciclofosfamida en comparación con fludarabina y ciclofosfamida en el tratamiento de la leucemia linfática crónica Economic evaluation of rituximab added to fludarabine plus cyclophosphamide versus fludarabine plus cyclophosphamide for the treatment of chronic lymphocytic leukemia
by: Luis Felipe Casado, et al.
Published: (2011)

Pulsoterapia com ciclofosfamida nos pênfigos: relato de sete casos Cyclophosphamide pulse therapy for pemphigus: report of seven cases
by: Nurimar C. Fernandes, et al.
Published: (2005)

Fludarabine/Cyclophosphamide Conditioning Regimen in Aplastic Anemia Patients Receiving Matched-Sibling Donor Transplant Is Non-inferior to ATG/Cyclophosphamide: A Single-Center Experience from Pakistan
by: Uzma Zaidi, et al.
Published: (2022)

Rituximab, Cyclophosphamide, and Corticosteroids for ANCA Vasculitis: The Good, the Bad, and the Ugly
by: Roberta Fenoglio, et al.
Published: (2020)

Development of fludarabine formulations in the treatment of chronic lymphocytic leukemia
by: Ann Janssens, et al.
Published: (2009)

Efectos adversos relacionados a infusión endovenosa de ciclofosfamida en pacientes de un hospital de referencia
by: María Elvira Miskinich Lugo, et al.
Published: (2022)

MYCOFENOLATUL DE MOFETIL VERSUS CICLOFOSFAMIDA ÎN SINDROMUL NEFROTIC CORTICOREZISTENT LA COPII
by: Florentina Cucer, et al.
Published: (2011)

Rituximab Therapy for Severe Cutaneous Leukocytoclastic Angiitis Refractory to Corticosteroids, Cellcept and Cyclophosphamide
by: Kamel El-Reshaid, et al.
Published: (2013)

Treatment of Membranous Nephropathy in Chinese Patients: Comparison of Rituximab and Intravenous Cyclophosphamide with Steroids
by: Xiaofan Hu, et al.
Published: (2024)

Conhecimento dos profissionais de enfermagem sobre a ciclofosfamida em um hospital universitário
by: Lidiane Aparecida Monteiro, et al.
Published: (2013)

Conhecimento dos profissionais de enfermagem sobre a ciclofosfamida em um hospital universitário
by: Lidiane Aparecida Monteiro, et al.
Published: (2013)

Granulomatosis polyangiitis associated with meningeal involvement: response to rituximab therapy after failure of cyclophosphamide
by: M. Benucci, et al.
Published: (2013)

Individual features of the pharmacokinetics of fludarabin phosphate in the treatment of patients with chronic lymphocytic leukemia
by: G. G. Rodionov, et al.
Published: (2021)

Targeted busulfan and fludarabine-based conditioning for bone marrow transplantation in chronic granulomatous disease
by: Hee Young Ju, et al.
Published: (2016)

Therapeutic advances of rituximab alone or plus other drugs for membranous nephropathy
by: Chao Zhang, et al.
Published: (2024)

A comparative study to evaluate the efficacy and cost of rituximab versus dexamethasone cyclophosphamide pulse in patients of pemphigus vulgaris
by: Sudip Das, et al.
Published: (2021)

Clinical Trial Simulation To Optimize Trial Design for Fludarabine Dosing Strategies in Allogeneic Hematopoietic Cell Transplantation
by: Jurgen B. Langenhorst, et al.
Published: (2020)

Combination therapy with rituximab and cyclophosphamide in the treatment of anti-neutrophil cytoplasmic antibodies (ANCA) positive pulmonary hemorrhage: case report
by: Lehman Thomas JA, et al.
Published: (2011)

Venous thromboembolism in a case with pemphigus vulgaris after infusion of rituximab plus systemic glucocorticoids and azathioprine: A possible adverse effect of rituximab?
by: Kuan-Jou Wu, et al.
Published: (2021)

ANÁLISIS COSTE-EFECTIVIDAD DEL TRATAMIENTO DE MANTENIMIENTO CON RITUXIMAB EN PACIENTES CON LINFOMA FOLICULAR QUE RESPONDEN A LA TERAPIA DE INDUCCIÓN EN PRIMERA LÍNEA
by: Antonio J Castro Gómez, et al.
Published: (2012)

Eficacia clínica del rituximab en pacientes con nefritis lúpica
by: Miriam Gabriela Méndez Quizhpi, et al.
Published: (2022)

Stem Cell Mobilization with G-CSF versus Cyclophosphamide plus G-CSF in Mexican Children
by: José Eugenio Vázquez Meraz, et al.
Published: (2016)

Prospective Validation and Refinement of a Population Pharmacokinetic Model of Fludarabine in Children and Young Adults Undergoing Hematopoietic Cell Transplantation
by: Jordan T. Brooks, et al.
Published: (2022)

Effective use of rituximab in combination with low dose cyclophosphamide in childhood onset systemic lupus erythematosus (SLE) with relapsing class IV nephritis
by: Miettunen PM, et al.
Published: (2008)

Corrigendum to "Stem Cell Mobilization with G-CSF versus Cyclophosphamide plus G-CSF in Mexican Children"
by: José Eugenio Vázquez Meraz, et al.
Published: (2016)

Função ovariana em mulheres lúpicas submetidas ao uso de ciclofosfamida em dois grandes centros de atendimento reumatológico de Curitiba, Estado do Paraná
by: Gislaine Paviani, et al.
Published: (2015)

Fludarabine, a Potential DNA-Dependent RNA Polymerase Inhibitor, as a Prospective Drug against Monkeypox Virus: A Computational Approach
by: Hisham N. Altayb
Published: (2022)

Uso de Rituximab en pacientes pediátricos con síndrome nefrótico córtico resistente, experiencia de un solo centro
by: Lina María Serna-Higuita, et al.
Published: (2014)

Obinutuzumab Plus Chemotherapy Compared with Rituximab Plus Chemotherapy in Previously Untreated Italian Patients with Advanced Follicular Lymphoma at Intermediate–High Risk: A Cost-Effectiveness Analysis
by: Bellone M, et al.
Published: (2021)

High Serum Estradiol Reduces Acute Hepatotoxicity Risk Induced by Epirubicin Plus Cyclophosphamide Chemotherapy in Premenopausal Women with Breast Cancer
by: Shunmin Huang, et al.
Published: (2021)

Lipidomics of cyclophosphamide 4‐hydroxylation in patients receiving post‐transplant cyclophosphamide
by: Sandi L. Navarro, et al.
Published: (2022)

Cardiovascular adverse events associated with cyclophosphamide, pegylated liposomal doxorubicin, vincristine, and prednisone with or without rituximab ((R)-CDOP) in non-Hodgkin's lymphoma: A systematic review and meta-analysis
by: Bin Lu, et al.
Published: (2022)

Cyclophosphamide-Induced Cardiomyopathy
by: Sumandeep Dhesi MD, et al.
Published: (2013)

De plus en plus de sélection dans un enseignement supérieur en segmentation Groupe de travail sur l'enseignement supérieur (GTES)
Published: (2023)

RITUXIMAB NO TRATAMENTO DE PÊNFIGO VULGAR REFRACTÁRIO
by: Iolanda Conde Fernandes, et al.
Published: (2013)

RITUXIMAB IN PEDIATRIC RHEUMATOLOGY
by: E.I. Alexeeva, et al.
Published: (2010)

RITUXIMAB IN PEDIATRIC RHEUMATOLOGY
by: E.I. Alexeeva, et al.
Published: (2010)

Rituximab en el tratamiento de esclerosis múltiple. Experiencia de un hospital de tercer nivel en México
by: Jaime I. Castro-Macías, et al.
Published: (2023)

Eficacia de la combinación de dos técnicas no invasivas como alternativa terapéutica en casos con melasma
by: Blanca Barroeta, et al.
Published: (2021)

Combinación de bupivacaína hiperbárica y fentanil como anestesia espinal en pacientes con fractura de cadera
by: Eduardo Piñeiro Casado, et al.